Search - tctmd.com

Displaying 61 - 80 of 113

Sort: Relevancy | Date

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Presentation ACC 2017

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

Presenter: Magnus Ohman

March 27, 2017

Presentation ACC 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presenter: Jeff Weitz

March 20, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation TCT 2016

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt

November 01, 2016

Presentation TCT 2016

TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Christine Chung

October 31, 2016

Presentation TCT 2016

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk

October 31, 2016

Presentation TCT 2016

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Duane S. Pinto, Dmitriy N. Feldman

October 30, 2016

Presentation

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Presenter: Muthia Vaduganathan

March 22, 2016

Presentation

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

Presenter: Paul Myles

February 24, 2016

Presentation

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Presenter: Matteo Bianco

January 20, 2016

Presentation TCT 2015

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Presenter: Pascal Vranckx, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

Is Dropping Aspirin the Magic Solution?

Presenter: John A. Bittl, Gary L. Schaer, Pascal Vranckx

October 12, 2015

Presentation TCT 2015

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

October 12, 2015

Presentation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Presenter: Ying Xian

May 27, 2015

Presentation ACC 2015

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Presenter: Marc S. Sabatine

March 14, 2015

Presentation

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Presenter: Martine Gilard

March 10, 2015

Presentation TCT 2014

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Presenter: Dietmar Trenk

September 16, 2014

Advertisement

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Is Dropping Aspirin the Magic Solution?

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content